Glow Blend 70mg
Triple-Action Tissue Repair & Regeneration Complex
$110.00$90.00
Grade: Research Grade / Analytical Standard
Purity: ≥99% Total Peptide Purity (HPLC Verified)
Format: Lyophilized (Freeze-Dried) Powder
Unit Size: 70 mg Total (BPC-157 10 mg / TB-500 10 mg / GHK-Cu 50 mg)
Product Overview
The Glow Blend 70mg is an advanced, high-yield triple-peptide complex engineered for multi-target scientific investigation into dermal matrix regeneration, tissue remodeling, and angiogenic cell signaling. By combining three complementary research compounds—BPC-157 (cytoprotective pentadecapeptide), TB-500 (Thymosin Beta-4 active fragment), and GHK-Cu (copper tripeptide-1)—into a single precision-dosed 70mg vial, this formulation provides research laboratories with an all-in-one matrix for studying multi-pathway tissue repair.
Co-lyophilized in precise ratio proportions, the Glow Blend eliminates the need for multi-vial co-reconstitution, ensuring standard consistency across complex cellular and dermal research protocols.
Key Research Features & Highlights
Triple-Pathway Synergy: Integrates BPC-157’s VEGF/NO signaling, TB-500’s actin-binding motility mechanisms, and GHK-Cu’s genomic collagen remodeling properties.
Extracellular Matrix (ECM) & Collagen Focus: Engineered to evaluate Type I/III collagen synthesis, elastin production, and decorin expression in dermal fibroblast models.
High-Yield 70mg Formulation: Pre-mixed at optimized ratios (10mg BPC-157 : 10mg TB-500 : 50mg GHK-Cu) for extended multi-assay testing and high-volume protocol runs.
Analytical Purity (≥99%): Independently batch-tested via High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS) to verify concentration accuracy and purity.
Primary Applications in Laboratory Research
Dermal Regeneration & Cosmeceutical Research: Investigating fibroblast proliferation, extracellular matrix restoration, and skin elasticity recovery in cellular models.
Synergistic Tissue Remodeling: Evaluating multi-pathway stimulation in tendon, ligament, and microvascular repair assays.
Cell Migration & Cytoskeletal Dynamics: Analyzing cell motility via TB-500’s actin sequestration alongside BPC-157’s cytoprotective survival pathways.
Pro-Angiogenic & Anti-Inflammatory Cascades: Researching endothelial cell sprouting, microvascular formation, and down-regulation of pro-inflammatory cytokines (TNF-α, IL-6).
Product Specifications
Attribute | Specification |
Active Compounds | BPC-157 (10 mg) + TB-500 (10 mg) + GHK-Cu (50 mg) |
Net Quantity | 70 mg total per vial |
Form | Lyophilized Powder (Characteristic Blue Tint) |
Purity Standard | ≥99% total peptide purity (HPLC verified) |
Solubility | Soluble in Bacteriostatic Water or Sterile Deionized Water |
Storage & Handling Protocols
Unreconstituted (Lyophilized): Store frozen at or below -20°C in a dry, dark environment protected from thermal fluctuations and direct light exposure.
Reconstituted Solution: Maintain at 2°C – 8°C following dilution with sterile solvent (e.g., Bacteriostatic Water) and utilize within 30 days. Avoid repeated freeze-thaw cycles.
Mandatory Research & Legal Disclaimer
FOR LABORATORY RESEARCH USE ONLY. This blend is provided exclusively for in vitro scientific research, analytical testing, and educational purposes. It is not approved for human or animal consumption, medical treatment, cosmetic application, or commercial drug formulation.